Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$596,670,219
+$187,211,016 QoQ
Shares Held
643,123
+14.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#10
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. ARGX ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
This page
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $596,670,219 | 643,123 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $409,459,203 | 560,711 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $436,328,582 | 518,852 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $320,916,774 | 435,106 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $236,633,779 | 429,291 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $519,154,377 | 877,150 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $577,200,870 | 938,538 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $504,540,411 | 930,749 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $352,564,418 | 819,841 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $273,194,430 | 693,880 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $248,377,796 | 652,887 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $272,810,396 | 554,910 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $216,858,238 | 556,432 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $203,617,201 | 546,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $238,787,908 | 630,330 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $66,060,240 | 187,113 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $54,323,052 | 143,378 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $16,794,355 | 53,263 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $16,405,700 | 46,848 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,304,026 | 17,563 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,685,851 | 15,564 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,906,740 | 10,555 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,280,984 | 28,158 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $20,886,877 | 79,563 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $24,791,064 | 110,070 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,186,282 | 24,188 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||